Clinical Trials Logo

Clinical Trial Summary

The goal of this multi-site double blinded randomized sham-controlled Phase II clinical trial is to test a novel, relatively low cost, low risk, and potentially high impact therapeutic intervention in older adults who are at increased risk for Alzheimer's disease. The intervention involves transcranial and intranasal delivery of near infrared (NIR) light via light emitting diodes, aka photobiomodulation. The overall hypothesis, based on animal and pilot studies, is that exposure to NIR stimulation will have beneficial effects on brain health via influence on mitochondrial function as measured by changes in 31P MRS-based markers of ATP, neural network changes in functional connectivity (rs-fMRI), and improved cognitive performance. To test this hypothesis, 168 older adults with subjective cognitive complaints, and a first-degree family history of Alzheimer's disease will be randomized to sham or real treatment groups. Neuromiaging and ocgnitive outcome measures will be obtained, before and after a 12-week intervention involving transcranial and intranasal NIR-PBM. The intervention protocol will involve "lab" and "home" sessions, and a 3 month post-intervention follow-up. This trial will determine: 1) whether NIR stimulation, relative to sham, improves performance on memory and executive tasks sensitive to hippocampal and frontal brain function in older adults with increased risk for Alzheimer's disease; 2) whether NIR stimulation, relative to sham, enhances brain function and connectivity measured by changes in MRS phosphorous ATP and resting state functional connectivity; and 3) how differences in demographic, neuroimaging, and Alzheimer-related risk factors influence the brain response to NIR stimulation versus sham in older adults with increased risk for Alzheimer's disease. Results will provide key insights into whether this novel NIR intervention can enhance cognition in older adults with increased risk for Alzheimer's disease and will provide the necessary data for a future Phase III randomized clinical trial.


Clinical Trial Description

This multi-site randomized sham controlled trial proposes to test a novel, non-invasive, low risk and low cost brain stimulation approach for enhancing cognition and brain health in cognitively normal older adults who are at increased risk for Alzheimer's disease. The intervention involves transcranial and intranasal delivery of near-infrared light (NIR; 808-904 nm) via light emitting diodes placed on the scalp or intranasally using a dosing that resulted in positive effects in our pilot studies. We plan to test the hypothesis that targeted NIR stimulation will have positive effects on brain health via influence on mitochondrial function as measured by changes in Magnetic Resonance Spectroscopy (MRS)-based markers of ATP, neural network changes as indexed by changes in functional connectivity based on resting state-fMRI, and improved cognitive performance. We plan to randomize 168 older adults, ages 65-89 years, to Active or Sham intervention conditions. To be included, participants must have subjective cognitive complaints, based on an index of Subjective Cognitive Impairment (SCI), and a family history of Alzheimer's disease in a first degree relative. Performance on standardized neuropsychological measures must be unimpaired psychometricallyl. The intervention itself will last for 12 weeks and include lab sessions (16 total) and daily at home sessions. In the lab, both transcranial and intranasal delivery of NIR light will be delivered using Medx and Vielight stimulation technologies, whereas the daily at home sessions will involve intranasal stimulation only. The sham and active conditions are identical in all respects except that sham devices will not deliver NIR stimulation. The primary outcome is an episodic memory measure involving spatial navigation that is linked to hippocampal function, sensitive to MCI and Alzheimer's disease, and an analogue to the Morris Water maze. Secondary outcomes include executive function task and neuroimaging indicators of ATP function (31-P MRS) and connectivity changes based on rs-fMRI. Exploratory outcomes include 'traditional' neuropsychological measures that are used clinically, along with measures and indices (e.g., APOE-4 status)that might potentially mediate or moderate study outcome. Assessments will occur at baseline (Month 1), after 12 weeks of intervention (Month 4), and 3 month post intervention (Month 7). Imaging outcomes will be assessed only at baseline and at Month 4. Our primary aim is focused on cognition and will test whether NIR intervention, relative to sham, will produce pre-post improvement on tasks of recent memory (primary outcome) and executive function in older adults who are at increased risk for Alzheimer's disease. Our secondary aim is focused on neuroimaging and will test whether NIR intervention, relative to sham, will enhance brain markers of MRS-ATP (secondary outcome) and increase functional connectivity as indexed by resting state fMRI. The 3rd aim is exploratory and will evaluated how baseline demographic, genetic, neuroimaging and other factors influence individual differences in cognitive outcome for NIR intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04018092
Study type Interventional
Source University of Florida
Contact Dawn Bowers, Ph.D.
Phone 352-273-6152
Email dawnbowers@phhp.ufl.edu
Status Recruiting
Phase Phase 2
Start date August 12, 2020
Completion date April 2025

See also
  Status Clinical Trial Phase
Completed NCT03988829 - Strategic Training to Optimize Neurocognitive Functions in Older Adults N/A
Completed NCT03141281 - Intervention Comparative Effectiveness for Adult Cognitive Training N/A
Completed NCT02985580 - Effects of Blueberry Juice Consumption on Cognitive Function in Healthy Older People N/A
Completed NCT05980286 - Impact of Musical Improvisation Training on Cognitive Function in Older Adults N/A
Active, not recruiting NCT02977819 - Study in Cognitively Intact Seniors Aiming to Assess the Effects of Meditation Training N/A
Completed NCT02714426 - A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults N/A
Completed NCT05462977 - Rhythmically Entrained Exercise in Community-Dwelling Older Adults N/A
Recruiting NCT05322343 - Biobank and Brain Health in Bordeaux.
Completed NCT00935493 - Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects N/A
Completed NCT00599508 - Nutritional Supplementation in Cognitive Aging N/A
Active, not recruiting NCT05455229 - Elucidating How Physical Activity and Sleep Relate to Optimal Cognitive Ageing
Terminated NCT04922710 - Physical Exercise for Augmenting Cognitive Health (PEACH) Early Phase 1
Recruiting NCT06006962 - Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP) N/A
Completed NCT04904991 - Three-month Chan-Chung Qigong Improves Physical Function Performance and Quality of Life N/A
Completed NCT05672771 - The Effects of Mixed Working Memory Training on Subsequent Training Gains Among Older Adults N/A
Completed NCT03629912 - Bingocize: A Novel Mobile Application for Older Adult Health N/A
Completed NCT03677726 - Improving Sleep Continuity Through Mindfulness Training for Better Cognitive Ageing. N/A